Development of a biosensor-based method for detection and isotyping of antibody responses to adenoviral-based gene therapy vectors.

[1]  J. Lafitte,et al.  Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. , 2001, The European respiratory journal.

[2]  R. Eisenberg,et al.  Two Distinct Binding Affinities of Poliovirus for Its Cellular Receptor* , 2000, The Journal of Biological Chemistry.

[3]  B. Fleckenstein,et al.  Detection of human serum antibodies against type-specifically reactive peptides from the N-terminus of glycoprotein B of herpes simplex virus type 1 and type 2 by surface plasmon resonance. , 2000, Journal of virological methods.

[4]  H. Ushijima,et al.  Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome. , 2000, Virology.

[5]  B. Lindqvist,et al.  Distinct cellular receptor interactions in poliovirus and rhinoviruses , 2000, The EMBO journal.

[6]  E. Giralt,et al.  Surface plasmon resonance screening of synthetic peptides mimicking the immunodominant region of C-S8c1 foot-and-mouth disease virus. , 1999, Vaccine.

[7]  K. Propert,et al.  Immune responses to adenovirus and adeno-associated virus in humans , 1999, Gene Therapy.

[8]  E. Nice,et al.  Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. , 1999, Analytical biochemistry.

[9]  Y Sawamura,et al.  Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. , 1999, Neuro-oncology.

[10]  S. Lowe,et al.  Clinical implications of p53 mutations , 1999, Cellular and Molecular Life Sciences CMLS.

[11]  D. Stuart,et al.  Determination of the Affinity and Kinetic Constants for the Interaction between the Human Virus Echovirus 11 and Its Cellular Receptor, CD55* , 1998, The Journal of Biological Chemistry.

[12]  R. Truitt,et al.  Characterization of human proliferative T cell responses to adenovirus. , 1995, The Journal of infectious diseases.

[13]  J. Roth,et al.  Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. , 1994, Journal of the National Cancer Institute.

[14]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[15]  H. Shepard,et al.  Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. , 1994, Human gene therapy.

[16]  M. Montenarh,et al.  The emerging picture of p53. , 1994, The International journal of biochemistry.

[17]  J. Roth,et al.  A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. , 1993, Cancer research.

[18]  J. Roth,et al.  Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. , 1993, Human gene therapy.

[19]  R. Redfield,et al.  Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1. , 1992, Journal of immunological methods.

[20]  D. Altschuh,et al.  Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. , 1992, Immunology letters.

[21]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[22]  R. Wigand,et al.  Worldwide epidemiology of human adenovirus infections. , 1983, American journal of epidemiology.

[23]  E. Norrby,et al.  A New Serological Technique for Identification of Adenovirus Infections 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.